MM MRD: Multiple Myeloma Minimal Residual Disease Panel
The EuroFlow™ approach to monitor MRD in MM by Next Generation Flow overcomes the current limitations of conventional flow cytometry. This approach includes the development of panels and protocols for the staining and acquisition of high number of events. Our kit has been designed to provide fast, ultrasensitive and accurate assessment of MM MRD.
CE/IVD reagents are only suitable for clinical use in the European Union and countries with EU conformity recognition agreements. Protected by patent.
The MM MRD kit is also available as a RUO product.